Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 8, 2005, Pages 2703-2706

  Okumura, Koichi ^a   Zhao, Mujun ^d   DePinho, Ronald A ^b,c   Furnari, Frank B ^a   Cavenee, Webster K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; THREONINE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENICITY; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; MSP58 ONCOGENE; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MICE; NUCLEAR PROTEINS; ONCOGENES; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 14544282456     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0409370102     Document Type: Article

References (18)

1. Maehama, T., Taylor, G. S. & Dixon, J. E. (2001) Annu. Rev. Biochem. 70, 247-279.
2. Eng, C. (2003) Hum. Mutat. 22, 183-198.
3. Larsen, M., Tremblay, M. L. & Yamada, K. M. (2003) Nat. Rev. Mol. Cell Biol. 4, 700-711.
4. Vazquez, F., Ramaswamy, S., Nakamura, N. & Sellers, W. R. (2000) Mol. Cell. Biol. 20, 5010-5018.
5. Lee, J. O., Yang, H., Georgescu, M. M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P. & Pavletich, N. P. (1999) Cell 99, 323-334.
6. Maier, D., Jones, G., Li, X., Schonthal, A. H., Gratzl, O., Van Meir, E. G. & Merlo, A. (1999) Cancer Res. 59, 5479-5482.
7. Raftopoulou, M., Etienne-Manneville, S., Self, A., Nicholls, S. & Hall, A. (2004) Science 303, 1179-1181.
8. Freeman, D. J., Li, A. G., Wei, G., Li, H. H., Kertesz, N., Lesche, R., Whale, A. D., Martinez-Diaz, H., Rozengurt, N., Cardiff, R. D., et al. (2003) Cancer Cell 3, 117-130.
9. Song, H., Li, Y., Chen, G., Xing, Z., Zhao, J., Yokoyama, K. K., Li, T. & Zhao, M. (2004) Biochem. Biophys. Res. Commun. 316, 1116-1123.
10. Ren, Y., Busch, R. K., Perlaky, L. & Busch, H. (1998) Eur. J. Biochem. 253, 734-742.
11. Bruni, R. & Roizman, B. (1998) J. Virol. 72, 8525-8531.
12. Bader, A. G., Schneider, M. L., Bister, K. & Hartl, M. (2001) Oncogene 20, 7524-7535.
13. Durocher, D. & Jackson, S. P. (2002) FEBS Lett. 513, 58-66.
14. Li, J., Lee, G. I., Van Doren, S. R. & Walker, J. C. (2000) J. Cell Sci. 23, 4143-4149.
15. Miller, S. J., Lou, D. Y., Seldin, D. C., Lane, W. S. & Neel, B. G. (2002) FEBS Lett. 528, 145-153.
16. Lin, D. Y. & Shih, H. M. (2002) J. Biol. Chem. 277, 25446-25456.
17. Aoki, M., Blazek, E. & Vogt, P. K. (2001) Proc. Natl. Acad. Sci. USA 98, 136-141.
18. Haendeler, J., Hoffmann, J., Rahman, S., Zeiher, A. M. & Dimmeler, S. (2003) FEBS Lett. 536, 180-186.